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Glucose can acutely reduce mitochondrial glutathione redox state in rat islets. However, whether
glucose-stimulated mitochondrial glutathione redox state relates to glucose-stimulated insulin secretion
(GSIS) remains unknown. We used genetically encoded redox-sensitive GFPs to target the mitochondria
to monitor glutathione redox changes during GSIS in rat pancreatic b-cells. The results showed that
mitochondrial glutathione was more reduced during GSIS, whereas inhibition of this glutathione
reduction impaired insulin secretion. In isolated rat pancreatic islets glutathione reduction in mito-
chondria and the ﬁrst phase of GSIS were concurrence at the early stage of glucose-stimulation. Our
results suggest that the glucose-induced glutathione reduction in mitochondria is primarily required for
the ﬁrst phase of GSIS.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Type 2 diabetes results from the combination of insulin resis-
tance and defective glucose stimulation of insulin secretion (GSIS)
by the endocrine pancreas. GSIS by pancreatic b-cells plays a critical
role in blood glucose homeostasis. Insulin secretion after the
stimulation of glucose occurs in two phases, in which the ﬁrst
phase release insulin within a few minutes of stimulation then it
declines. The second phase begins a few minutes after the ﬁrst
phase and can reach peak at about 30e40 min [1]. This acute
glucose effect depends on the acceleration of its oxidation by
glycolysis and the mitochondrial Krebs cycle, which result in these-stimulated insulin secre-
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including NAD(P)H and ATP. Once the ATP: ADP ratio increases in
the cytoplasm, the plasmalemmal ATP-sensitive potassium channel
(KATP) closes, resulting in the depolarization of the plasma mem-
brane, which triggers the opening of the voltage-gated Ca2þ
channel [2]. This results in an inﬂux of Ca2þ into the cell that trig-
gers the exocytosis of insulin granules. The KATP-dependent
mechanism may act as the ‘triggering signal’ responsible for the
ﬁrst phase of insulin secretion. Evidence is emerging that in addi-
tion to ATP and the ATP/ADP ratio, reactive oxygen species (ROS)
derived from glycolytic and respiratory metabolism inb-cells, in
particular H2O2, serve as additional metabolic signals to elicit GSIS
[3e5].
Recently, using the redox-sensitive ﬂuorescent probe roGFP2
fused with Grx1, Dr. Jean-Christophe Jonas's group found that
glucose and other nutrients acutely reduce mitochondrial but not
cytosolic/nuclear EGSH in rat islets. They also conﬁrmed the obser-
vation in human islets [6]. But whether there is a relation between
mitochondrial glutathione redox state and GSIS still remains un-
known. Also, they didn't report where the reduced glutathione
comes from during glucose stimulation.
In the present study, we used subcellular redox probe mito-
Grx1-roGFP2 to detect redox changes in mitochondria during thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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between the glutathione reduction state and insulin secretion. We
showed that the glucose-induced glutathione reduction in mito-
chondria is primarily required for the ﬁrst phase of GSIS. We also
found that the reduced glutathione resulted from glutathione
synthesis and reduction of oxidised glutathione.
2. Materials and methods
2.1. Materials
1,4-Dithiothreitol (DTT) and puromycin dihydrochloride were
purchased from Amresco. Diamide, carmustine (BCNU), L-buthio-
nine-sulfoximine (BSO), Thiazolyl blue tetrazolium bromide (MTT)
and D-(þ)-glucose were purchased from SigmaeAldrich.
2.2. Cell culture
Rat insulinoma INS-1E cells, kindly provided by Drs. CB Woll-
heim and P Maechler (University Medical Center, Switzerland),
were cultured in RPMI 1640 supplemented with 10% heat-
inactivated fetal bovine serum, 1 mM sodium pyruvate, 50 mM 2-
mercaptoethanol, 2 mM glutamine, 10 mM HEPES, and 100 U/ml
penicillin/streptomycin, as previously described [7,8]. HEK-293
cells (human embryonic kidney cells) were maintained in DMEM
supplemented with 10% foetal bovine serum and 100 U/ml peni-
cillin/streptomycin at 37 C and 5% CO2.
2.3. Plasmids
pLPCX mito-Grx1-roGFP2 plasmid was kindly provided by Dr.
Tobias P. Dick (German Cancer Research Center, Heidelberg, Ger-
many). The cDNA encoding mito-Grx1-roGFP2 was ampliﬁed by
PCR from pLPCX mito-Grx1-roGFP2 (primer forward: 50-TTCTA-
GAGCCACCATGGCCTCCACTCGTGT-30; primer reverse: 50-
ATTTGCGGCCGCTTACTTGTACAGCTCGTCCAT-30) and was inserted
into the lentiviral expression vector pCDH-CMV.
2.4. Retroviral and lentiviral infection
The HEK-293 cells were co-transfected with a pCL-10A1
retrovirus packaging vector with pLPCX mito-Grx1-roGFP2 using
Lipofectamine™ 2000 (Invitrogen) according to the manufac-
turer's protocol. After a 48 h infection, the retrovirus particles
were collected from the HEK-293 cells and transfected into INS-1E
cells. The INS-1E cell lines that stably expressed mito-Grx1-
roGFP2 were identiﬁed in the presence of 2 mg/ml puromycin
dihydrochloride.
The HEK-293T cells were co-transfected with psPAX2 and
pMD2.G lentivirus packaging vectors with pCDH mito-Grx1-
roGFP2 using Lipofectamine™ 2000 (Invitrogen) according to the
manufacturer's protocol. After a 48-h infection, the lentivirus par-
ticles were collected from the HEK-293T cells and transfected into
rat pancreatic islets. Two days later, the pancreatic islets expressing
mito-Grx1-roGFP2 were measured by confocal microscopy.
2.5. MTT assay
The effect of BCNU and BSO on INS-1E mito-Grx1-roGFP2 cell
viability was tested using MTT assay [9]. Approximately, 2.4  106
cells were plated in a 96-well plate in triplicate and cultured at
37 C in the presence of 5% CO2 for 24 h. They were exposed to
various concentrations of BCNU and BSO for 24 h. At the end of the
treatment, 0.05% MTT reagent (Sigma) was added to each well and
kept for 3 h in incubation at 37 C. Then, 100 mL of iso-propylalcohol was added to each well of the 96-well plate to dissolve
the MTT formazan crystals. Absorbance was measured at a wave-
length of 570 nm and absorbance measured at wavelength 690 nm
was subtracted as background. Results were calculated as per-
centages of the BCNU and BSO untreated cells which were set as
100%.
2.6. Fluorescence microscopy
INS-1E cells that stably expressed mito-Grx1-roGFP2 were
seeded on a 35-mm culture-dish. After growing for approximately
48 h, the cells were incubated with 100 nM MitoTracker Orange
CMTMRos (M-7510; Invitrogen) for 20 min, washed three times
with PBS buffer, and incubated with RPMI 1640 medium without
phenol red (Invitrogen). Image observations were performedwith a
Plan-Apochromat 63  1.4 oil objective on a Zeiss LSM 710 Con-
foCor 3 microscope. A 488-nm laser line was used to excite mito-
Grx1-roGFP2 with a 493e578-nm emissionwindow, and a 568-nm
laser line was used to excite the Mito Tracker within a 578e712-nm
emission window. Scanning was performed using the “line mode”
with a 639 639 format, 8 bit depth, 2 line average, and a 0.8-mm
pinhole.
Dynamic measurements of mito-Grx1-roGFP2 in rat pancre-
atic islets were carried out by using confocal microscopy (Nikon
A1). The ﬂuorescence ratio of mito-Grx1-roGFP2 (Ex. 405 and
488 nm, Em. 500e550 nm) was measured every 30 s. The results
were normalized to the average ﬂuorescence ratio of the ﬁrst
10 min.
2.7. Live-cell ﬂuorescence measurement with a microplate reader
INS-1E cells that stably expressed mito-Grx1-roGFP2 were
seeded on 96-well plates (Corning) and were pre-incubated for 1 h
at 37 C in KrebseRinger bicarbonate buffer (KRBH buffer, 135 mM
NaCl, 3.6 mM KCl, 5 mM NaHCO3, 0.5 mM NaH2PO4, 0.5 mMMgCl2,
1.5 mM CaCl2, 10 mM HEPES and 0.1% BSA, pH 7.4) containing
2.8 mM glucose [7]. Dual-excitation ratios were obtained with a
BioTek Synergy NEO microplate spectrophotometer (BioTek) with
405 nm and 488 nm excitation and 520 nm emission for both
excitation wavelengths [10]. The cell temperature was maintained
at 37 C during the detection.
2.8. Pancreatic islet isolation
Pancreatic islets were isolated from male Wistar rats
(180e220 g) by collagenase (Roche) digestion and subsequent
centrifugation in a Histopaque-1077 (Sigma) gradient as described
[11]. The islets were hand-picked under a stereomicroscope. They
were then either used for islet perifusion or cultured at 37 C in the
presence of 5% CO2 with RPMI 1640 supplemented with 10% heat-
inactivated fetal bovine serum, 1 mM sodium pyruvate, 50 mM 2-
mercaptoethanol, 2 mM glutamine, 10 mM HEPES, and 100 U/ml
penicillin/streptomycin.
2.9. Islet perifusion and insulin secretion
Islet perifusion experiments were carried out by using a high-
capacity, automated perifusion system (Biorep Inc), as described
[12,13]. Size-matched 50 islets were loaded onto each column and
immobilized in Bio-Gel P-4 Gel (Bio-Rad). The islets were then
perifused with KRBH buffer containing 2.8 mM glucose at a peri-
fusion rate of 100 ml/min for 1 h. Next, the islets were perifused
with KRBH buffer containing 16.7 mM glucose for 1 h. The peri-
fusate was collected in an automatic fraction collector designed for
a 96-well plate format. Perifusates were collected every minute.
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ELISA kit (Mercodia, Sweden) following the manufacturer's
instructions.
To measure insulin secretion from INS-1E cells, the cells
were seeded onto 24-well plates and pre-incubated for 1 h at
37 C in KRBH buffer containing 2.8 mM glucose. The cells were
then incubated in KRBH buffer supplemented with the indi-
cated concentrations of glucose for 1 h. The insulin in the media
was measured using a rat insulin ELISA kit (Mercodia, Sweden)
[7].Fig. 1. The effects of glucose on INS-1E cells that stably expressed mito-Grx1-roGFP2. (A) T
100 nM MitoTracker for 20 min and then examined by ﬂuorescence microscopy. The overla
and C) INS-1E cells stably expressing mito-Grx1-roGFP2 were excited at 405 and 488 nm in
The cells were treated with diamide (B) or DTT (C) at the arrow-indicated time points. (D)I
containing 2.8 mM glucose for 1 h and were then stimulated with 16.7 mM glucose at th
described in (B and C). The traces were ﬁrst normalized individually to the average value
mean ± S.E.M. (n ¼ 3).3. Results
3.1. Glucose speciﬁcally induces glutathione reduction in the
mitochondria
We generated INS-1E cells that stably express mito-Grx1-
roGFP2 by retroviral transduction (Materials and methods). We
detected the localisation of mito-Grx1-roGFP2 in these stable cell
lines. The confocal imaging of the INS-1E cells that expressed mito-
Grx1-roGFP2 indicated that this probe exclusively targetedhe cultured INS-1E cells that stably expressed mito-Grx1-roGFP2 were incubated with
y of mito-Grx1-roGFP2 and MitoTracker is shown in the right panel. Scale bar, 5 mm. (B
a microplate spectrophotometer, and the ratio of emissions at 525 nm was calculated.
NS-1E cells stably expressing mito-Grx1-roGFP2 were pre-incubated with KRBH buffer
e arrow-indicated time points. The ﬂuorescence intensity of the cells was detected as
of the seven earliest time points in each experiment. The results are presented as the
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speciﬁc mitochondrial marker MitoTracker (Fig. 1A). Next, we
examined the ability of mito-Grx1-roGFP2 to monitor changes in
the mitochondrial redox of living cells. When the cells were treated
with the oxidation reagent diamide, the microplate spectropho-
tometer detected an increase in the 405/488-nm ratio in the cells
that expressed mito-Grx1-roGFP2; this increase occurred in a
diamide concentration-dependent manner (Fig. 1B). However, the
application of the reducing reagent DTT to the cells caused a
decrease in the 405/488-nm ratio in a DTT concentration-
dependent manner (Fig. 1C). Taken together, the present results
show that the mito-Grx1-roGFP2 probes can speciﬁcally detect the
redox potentials of the c mitochondria.
By using mito-Grx1-roGFP2-monitoring mitochondrial redox in
the present study, we analysed redox changes in the mitochondria
of INS-1E cells that were treated with low and high concentrations
of glucose. The results detected by microplate spectrophotometer
showed that the 405/488-nm ratio of the INS-1E cells expressing
mito-Grx1-roGFP2 decreased by approximately 10% under the
16.7 mM glucose treatment (Fig. 1D). The result indicate that the
mitochondrial glutathione reduction in INS-1E cells is enhanced by
the high glucose treatment.
3.2. Glutathione reduction in mitochondria highly correlates with
glucose-stimulated insulin secretion
Because a high glucose concentration is required for insulin
secretion in pancreatic beta-cells, we investigated the relation be-
tween insulin secretion andmitochondrial glutathione reduction inFig. 2. The relationship between mitochondrial glutathione reduction and GSIS. (A) The insu
the cells were incubated in KRBH buffers containing the indicated glucose concentrations for
(B) The glutathione reduction in mitochondria of INS-1E cells that stably expressed mito-Grx
were then stimulated by the indicated glucose concentrations at the arrow-indicated time p
regression linking insulin secretion to glutathione reduction in mitochondria was calculateINS-1E cells under various glucose concentrations. On one hand,
the result showed that the insulin secretion levels of INS-1E cells
that were treated with 11 mM or higher glucose concentrations
were much higher than those treated with low glucose concen-
trations (2.8 and 5.6 mM) (Fig. 2A). On the other hand, the micro-
plate spectrophotometer measurements indicated that the 405/
488-nm ratio of the INS-1E cells expressing mito-Grx1-roGFP2
that were treatedwith 11mMor higher glucose concentrations was
much lower than that treated with low glucose concentrations (2.8
and 5.6 mM) (Fig. 2B).
Interestingly, the 5.6 mM glucose treatment slightly increased
the insulin secretion of INS-1E cells compared with 2.8 mM glucose
(Fig. 2A), and it accordingly decreased the 405/488-nm ratio of the
cells (Fig. 2B). These results suggest that the degree of glutathione
reduction in mitochondria is highly associated with the levels of
glucose-stimulated insulin secretion. The lower the glutathione
reduction in mitochondria, the higher the insulin secretion will be.
Based on these data, we calculated the association coefﬁcient using
SigmaPlot. The regression that linked glutathione reduction in
mitochondria to insulin secretion (r ¼ 0.9526) is highly signiﬁcant
(P < 0.01; Fig. 2C).
3.3. The glucose-stimulated glutathione reduction in mitochondria
is involved in insulin secretion
Reduced glutathione (GSH) is synthesized from L-glutamate
with the help of two enzymes, namely g-glutamylcysteine syn-
thetase (g-GCS) and glutathione synthetase (GS) (Fig. 4A). Previous
reports showed that GSH synthesis could be impaired by thelin secretion of INS-1E cells that stably expressed mito-Grx1-roGFP2 was detected after
1 h. The values are the mean ± S.E.M. from three independent experiments. *, P < 0.05.
1-roGFP2 were pre-incubated with KRBH buffer containing 2.8 mM glucose for 1 h and
oint. The ﬂuorescence intensity of the cells was detected as described in Fig. 1(C) The
d (r ¼ 0.9526, P < 0.05).
Fig. 3. The inhibition of glutathione reduction-impaired insulin secretion. (A) The glutathione redox pathway and its inhibitors; BSO inhibits GCS and BCNU inhibits GR. (B)
Detection of cell viability of INS-1E cells that stably expressed mito-Grx1-roGFP2 after being exposed to BCNU and BSO at indicated concentrations for 24 h (C) INS-1E cells that
stably expressed mito-Grx1-roGFP2 were incubated with medium containing the indicated concentrations of both BCNU and BSO for 24 h and were then incubated with KRBH
buffer containing 2.8 mM glucose and stimulated with 16.7 mM glucose at the arrow-indicated time point. The ﬂuorescence intensity of the cells was detected as described in Fig. 1.
The results are presented as the mean ± S.E.M. (n ¼ 3). (D) The insulin secretion of INS-1E cells stably expressing mito-Grx1-roGFP2 were detected under BSO and BCNU treatment
as described in Fig. 4 C. The values are the mean ± S.E.M. from three independent experiments. *, P < 0.05 and **, P < 0.01.
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more, GSH is also derived from the reduction of oxidised gluta-
thione (GSSG) by glutathione reductase (GR), which could be
inhibited by the chemical compound BCNU [16] (Fig. 3A). First, we
used BSO and BCNU independently to block GSH synthesis or
reduction of oxidised glutathione. When BSO was added, the
mitochondrial glutathione still became more reduced after
16.7 mM glucose stimutation (Supplementary Fig. A), and didn't
affect GSIS (Supplementary Fig. B). After BCNU was added, the
mitochondrial glutathione also became more reduced after
16.7 mM glucose stimutationwith the insulin secretion the same as
control cells (Supplementary Fig. C and D). So, we speculated that
the mitochondrial glutathione may have two resources: the GSH
synthesis in the cellular and the reduction of oxidised glutathione
by glutathione reductase.
Thus, we added both BSO and BCNU to INS-1E cells to inhibit
GSH production, which did not decrease cell viability (Fig. 3B). In
the presence of both drugs, the 405/488-nm ratio of INS-1E cells
expressing mito-Grx1-roGFP2 under 16.7 mM glucose treatment
was signiﬁcantly higher than the cells without the drug treatment
(Fig. 3C), indicating that glucose-stimulated glutathione reduction
is impaired by these drugs.
We measured the levels of glucose-stimulated insulin secretion
in the presence of the indicated concentrations of both drugs. Theresults indicated that insulin secretion was inhibited by the drug
treatments in a dose-dependent manner (Fig. 3D). The inhibitory
effects of insulin secretion were inversely correlated with the
glutathione reduction levels (compare Fig. 3C with D). Taken
together, these observations suggest that glutathione reduction in
mitochondria is required by glucose-stimulated insulin secretion
and the reduced glutathione resulted from both synthesis in the
cellular and the reduction of oxidised glutathione by glutathione
reductase.
3.4. Glucose-induced glutathione reduction in mitochondria is
primarily required for the ﬁrst phase of GSIS
GSIS is known to occur in two phases. The ﬁrst phase occurs
within a few minutes of glucose stimulation and initiates insulin
secretion that is controlled by the triggering signalling pathway.
Insulin secretion in the second phase can peak at approximately
30e40 min and is regulated by the amplifying signalling pathway
[1,17]. We realized that the time points for measuring intracellular
redox state were important. For example, ROS changes were varied
across the previous experiments as measured at different time
points. Dr. Rebelato's group observed that the intracellular ROS
levels were signiﬁcantly decreased within 15 min after glucose
stimulation [18], whereas the increased ROS levels in the
Fig. 4. Glutathione reduction in mitochondria and the ﬁrst phase of GSIS at the early
stage of glucose-stimulation. Rat pancreatic islets were isolated and transfected with
lentivirus particles containing mito-Grx1-roGFP2. The ﬂuorescence intensity was
monitored by confocal ﬂuorescence microscopy. The pancreatic islets were perifused
with KRBH buffer containing 2.8 mM glucose for 1 h and were then stimulated with
16.7 mM glucose at the arrow-indicated time point. The values are the mean ± S.E.M.
from three independent islet isolation.
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treatment [3].
In the present study, we found that the signiﬁcant increase in
reduced glutathione in mitochondria was detected within 2 min
after the high glucose treatment, but no such signiﬁcant redox
change was detected in glutathione after that time point (Figs. 2
and 3B). These results suggest that the mitochondrial redox state
in the earliest stage of glucose stimulation must be adjusted to a
more reduced state. We therefore investigated the relationship
between the ﬁrst phase of insulin secretion and glutathione
reduction in mitochondria under glucose stimulation in rat
pancreatic islets (Materials and Methods). After the stimulation of
16.7 mM glucose, the ﬁrst phase of insulin secretion in the isolated
islets reached its peak at about 2 min and then fell down within
10 min (Fig. 4). Importantly, mito-Grx1-roGFP2 ﬂuorescence ratio
quickly decreased within 5 min and then kept at the similar level
within 1 h (Fig. 4). These results indicate that glutathione reduction
in mitochondria and the ﬁrst phase of GSIS are concurrence at the
early stage of glucose-stimulation. In conclusion, the present re-
sults suggest that the glucose-induced glutathione reduction in
mitochondria is primarily required for the ﬁrst phase of GSIS.
4. Discussion
In the present study, we demonstrate that glucose could induce
glutathione reduction in mitochondria (Fig. 1D) in INS-1E cells, and
this phenomenon is tightly associated with insulin secretion
(Fig. 2). Once the mitochondrial glutathione reductionwas blocked,
the insulin secretion in INS-1E cells was reduced (Fig. 3). Gluta-
thione reduction in mitochondria is required by glucose-stimulated
insulin secretion and the reduced glutathione resulted from both
synthesis in the cellular and the reduction of oxidised glutathione
by glutathione reductase (Fig. 3). The glucose-induced glutathione
reduction in mitochondria is primarily involved in triggering the
signalling pathway to regulate the ﬁrst phase of GSIS (Fig. 4).
Glutathionylation, a form of S-thiolation where protein cyste-
ines form a disulﬁde bond with the cysteine of the tripeptide
glutathione (GSH) [19], has been known for a long time. Gluta-
thionylation is reversible and reduction of PSSG can take place
spontaneously, when the GSH/GSSG ratio is high, or can becatalysed by protein thiol-disulﬁde oxidoreductases [20]. Regard-
less the molecular mechanisms, S-glutathionylation is one of the
most important protein post-translational modiﬁcations and is
viewed as a regulatory device for proteins involved in energy
metabolism, redox signaling, and apoptosis [21e23]. In mitochon-
dria, aconitase [24], a-ketoglutarate dehydrogenase [25], isocitrate
dehydrogenase [26], succinyl-CoA transferase [27] can be inhibited
upon glutathionylation. Glutathionylation of UCP2 can deactivate it
and inhibit proton leak through UCP2 [28]. It was found that UCP2
became deglutathionylated following a 60-min glucose treatment
[29]. Until now, UCP2 is the ﬁrst and the only protein that undergos
glutathionylation control during GSIS. As gultathionylation can
impact the activity of many proteins, including UCP2 which have
a negative inﬂuence in GSIS, we propose that the glutathiony
reduction in mitochondria during GSIS may lead to the degluta-
thionylation of some proteins which play important roles in GSIS.
We used anti-GSH antibody to immunoprecipitate glutathionylated
proteins from mitochondria of INS-1E cells and identiﬁed by
LCeMS/MS analysis. We found most of the glutathionylated pro-
teins located at mitochondria complexes (data not shown). Further
study should be carried out focusing on individual proteins which
deglutathionylated after glucose stimulation and thus inﬂuence
insulin secretion.
In conclusion, we propose that the intracellular redox state in
the earliest stage of glucose stimulation must be adjusted to a more
reduced state. This reduced state mainly retained by reduced
glutathione which comes from GSH synthesis or the reduction of
oxidised glutathione. The present data also suggest that the
glucose-induced glutathione reduction in mitochondria is primar-
ily involved in triggering the signalling pathway to regulate the ﬁrst
phase of GSIS.
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